Association between the p22 phox 930A/G polymorphism and blood pressure in normotensive subjects

Hypertension Research

Volumn 33, Issue 8, 2010, Pages 786-787

  Kim, Cheol Ho ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; ANGIOTENSINOGEN; OXIDIZED LOW DENSITY LIPOPROTEIN; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD PRESSURE VARIABILITY; DIET; DNA POLYMORPHISM; ESSENTIAL HYPERTENSION; GENE LOCUS; GENETICS; GENOTYPE; HEART FAILURE; HEART INFARCTION; HEREDITARY HYPERTENSION; HUMAN; HYPERTENSION; KIDNEY FAILURE; NOTE; OXIDATIVE STRESS; PATHOGENESIS; PHYSICAL ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT INTAKE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STROKE; UPREGULATION; VASCULARIZATION;

BLOOD PRESSURE; HUMANS; HYPERTENSION; NADPH OXIDASE; POLYMORPHISM, GENETIC; PREVALENCE; RISK FACTORS;

EID: 77955345900     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.117     Document Type: Note

References (17)

1. Chobanian AV. Shattuck lecture. The hypertension paradox-more uncontrolled disease despite improved therapy. N Engl J Med 2009; 361: 878-887.
2. Franco V, Calhoun DA, Oparil S. Pathophysiology of hypertension. In: Black HR, Elliott WJ (eds). Hypertension: A Companion to Braunwald's Heart Disease. Saunders: Philadelphia, 2007, pp 25-28.
3. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill Jr JR, Ulick S, Milora RV, Findling JW, Canessa CM, Rossier BC, Lifton RP. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994; 79: 407-414.
4. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104: 545-556.
5. Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med 2003; 139: 761-776.
6. Sethi AA, Nordestgaard BG, Gronholdt ML, Steffensen R, Jensen G, Tybjaerg-Hansen A. Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease. Hypertension 2003; 41: 1202-1211.
7. Sookoian S, Gianotti TF, Gonzalez CD, Pirola CJ. Association of the C-344Taldosterone synthase gene variant with essential hypertension: a meta-analysis. J Hypertens 2007; 25: 5-13.
8. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15 (12 Part 2): 1579-1592.
9. Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietinck R, Fagard R. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 1999; 17: 9-17.
10. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003; 42: 1075-1081.
11. Lassegue B, Griendling KK. NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 2010; 30: 653-661.
12. Moreno MU, San Jose G, Fortuno A, Beloqui O, Diez J, Zalba G. The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension. J Hypertens 2006; 24: 1299-1306.
13. San Jose G, Moreno MU, Olivan S, Beloqui O, Fortuno A, Diez J, Zalba G. Functional effect of the p22phox-930A/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension. Hypertension 2004; 44: 163-169.
14. Moreno MU, San Jose G, Fortuno A, Beloqui O, Redon J, Chaves FJ, Corella D, Diez J, Zalba G. A novel CYBA variant, the-675A/T polymorphism, is associated with essential hypertension. J Hypertens 2007; 25: 1620-1626.
15. Xaplanteris P, Vlachopoulos C, Baou K, Vassiliadou C, Dima I, Ioakeimidis N, Stefanadis C. The effect of p22phox-930A/G, A640G and C242T polymorphisms of NADPH oxidase on peripheral and central pressures in healthy, normotensive individuals. Hypertens Res 2010; 33: 814-818.
16. Ehret GB, Morrison AC, O'Connor AA, Grove ML, Baird L, Schwander K, Weder A, Cooper RS, Rao DC, Hunt SC, Boerwinkle E, Chakravarti A. Replication of the Wellcome Trust genome-wide association study of essential hypertension: the Family Blood Pressure Program. Eur J Hum Genet 2008; 16: 1507-1511.
17. Sober S, Org E, Kepp K, Juhanson P, Eyheramendy S, Gieger C, Lichtner P, Klopp N, Veldre G, Viigimaa M, Doring A, Putku M, Kelgo P, Shaw-Hawkins S, Howard P, Onipinla A, Dobson RJ, Newhouse SJ, Brown M, Dominiczak A, Connell J, Samani N, Farrall M, Caulfield MJ, Munroe PB, Illig T, Wichmann HE, Meitinger T, Laan M. Targeting 160 candidate genes for blood pressure regulation with a genome-wide genotyping array. PLoS One 2009; 4: e6034.